Thalomid (Thalidomide) Capsules: A Review of the First 18 Months of Spontaneous Postmarketing Adverse Event Surveillance, Including Off-Label Prescribing

Author： Clark T.E.   Edom N.   Larson J.   Lindsey L.J.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.2, 2001-01, pp. : 87-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-label prescribing in a French hospital

By Cras Audrey   Conscience Marie-Agnès   Rajzbaum Gérald   Lillo-Le Louët Agnès   Lopez Nathalie   Tersen Isabelle   Bezie Yvonnick  

Pharmacy World and Science, Vol. 29, Iss. 2, 2007-04 ,pp. : 97-100

Springer Publishing Company

Access to resources Recommend Favorite

Off-Label Prescribing in Older Patients

By Jackson Stephen H.D.  

Drugs & Aging, Vol. 29, Iss. 6, 2012-06 ,pp. : 427-434

Adis International

Access to resources Recommend Favorite

Off-label prescribing "common" in Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 653, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Thalidomide prescribed off-label by physicians in Japan

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 434, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

IPA calls for better monitoring of off-label prescribing

By  

Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite